Aclaris Therapeutics Cash from Investing (TTM) Insights

Aclaris Therapeutics Inc (ACRS)

1.21 0.00 (0.00%) USD | NASDAQ | Apr 15, 16:00

1.215 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	46.22M
September 30, 2023	41.37M
June 30, 2023	10.06M
March 31, 2023	8.494M
December 31, 2022	12.63M
September 30, 2022	0.75M
June 30, 2022	-38.14M
March 31, 2022	-62.39M
December 31, 2021	-167.63M
September 30, 2021	-160.76M
June 30, 2021	-117.85M
March 31, 2021	-82.87M
December 31, 2020	6.387M
September 30, 2020	65.13M
June 30, 2020	81.57M
March 31, 2020	111.00M
December 31, 2019	105.68M

Date	Value
September 30, 2019	-21.26M
June 30, 2019	-32.54M
March 31, 2019	-38.21M
December 31, 2018	9.367M
September 30, 2018	58.31M
June 30, 2018	8.057M
March 31, 2018	-5.455M
December 31, 2017	-55.69M
September 30, 2017	-111.94M
June 30, 2017	-76.22M
March 31, 2017	-66.12M
December 31, 2016	-61.90M
September 30, 2016	-53.57M
June 30, 2016	-62.56M
March 31, 2016	-67.52M
December 31, 2015	-76.95M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-167.63M

Minimum

Dec 2021

111.00M

Maximum

Mar 2020

-10.22M

Average

6.387M

Median

Dec 2020

Cash from Investing (TTM) Benchmarks